Why is Dhampur Bio falling/rising?

As of 17-Jul, Dhampur Bio Organics Ltd's stock is currently priced at 96.93, reflecting a decline of 2.82 points or 2.83%. Today's price summary indicates that the stock has underperformed its sector by 2.4% and has experienced a trend reversal after two consecutive days of gains. The stock reached an intraday high of Rs 103.06 but fell to a low of Rs 95.8, with more trading volume occurring closer to the lower price. Over the past week, the stock has shown a positive return of 6.52%, but it has significantly underperformed over the last year with a return of -30.42%. The company has recently reported positive results after six quarters of losses, with net sales growing by 24.98%, but its profitability has been declining, evidenced by a 64.6% drop in profits over the past year. Additionally, the stock's weak long-term fundamentals, including a high debt-to-EBITDA ratio and low return on equity, contribute to investor caution.
In the broader market context, while the Sensex has generated a return of 0.83% over the past month, Dhampur Bio's stock has outperformed with a 20.29% increase during the same period. However, its year-to-date performance remains negative at -15.38%, contrasting sharply with the Sensex's positive return of 5.27%. The lack of domestic mutual fund investment in the company may indicate a lack of confidence among institutional investors, further impacting the stock's performance. Overall, while there are some positive indicators in the company's recent results, the persistent issues with profitability and debt levels, combined with the stock's historical underperformance, are likely contributing to its current decline.